Previous close | 0.7465 |
Open | 0.7402 |
Bid | 0.6885 x 100 |
Ask | 0.7112 x 100 |
Day's range | 0.6975 - 0.7402 |
52-week range | 0.2450 - 4.0380 |
Volume | |
Avg. volume | 1,905,717 |
Market cap | 45.295M |
Beta (5Y monthly) | 1.91 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The Renalytix share price erupted this week as the AI diagnostics firm received a takeover bid. But is it too late to buy this penny stock? The post Is Renalytix the best penny stock to buy today? appeared first on The Motley Fool UK.
Renalytix AI PLC Sponsored ADR (RNLX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Renalytix AI PLC Sponsored ADR (RNLX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.